3D Pharmacophoric Similarity improves Multi Adverse Drug Event Identification in Pharmacovigilance
暂无分享,去创建一个
[1] D. Bates,et al. The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .
[2] C L Brooks,et al. Do active site conformations of small ligands correspond to low free-energy solution structures? , 1998, Journal of computer-aided molecular design.
[3] James G. Nourse,et al. Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..
[4] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[5] W. DuMouchel,et al. Comparative Performance of Two Quantitative Safety Signalling Methods , 2006, Drug safety.
[6] Joelle M. R. Gola,et al. Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery , 2006, Expert opinion on drug metabolism & toxicology.
[7] A. Bender,et al. Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure , 2007, ChemMedChem.
[8] E. B. Wedebye,et al. QSAR models for reproductive toxicity and endocrine disruption in regulatory use – a preliminary investigation† , 2008, SAR and QSAR in environmental research.
[9] Romualdo Benigni,et al. Predictivity and Reliability of QSAR Models: The Case of Mutagens and Carcinogens , 2008, Toxicology mechanisms and methods.
[10] Luis G Valerio,et al. In silico toxicology for the pharmaceutical sciences. , 2009, Toxicology and applied pharmacology.
[11] Richard Morrison,et al. Exploratory drug safety: a discovery strategy to reduce attrition in development. , 2009, Journal of pharmacological and toxicological methods.
[12] M. Milik,et al. Mapping adverse drug reactions in chemical space. , 2009, Journal of medicinal chemistry.
[13] A Bate,et al. Decision support methods for the detection of adverse events in post-marketing data. , 2009, Drug discovery today.
[14] Santiago Vilar,et al. Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors. , 2010, Journal of molecular graphics & modelling.
[15] Navdeep Jaitly,et al. A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways , 2010, PloS one.
[16] Luis G Valerio,et al. In silico toxicology models and databases as FDA Critical Path Initiative toolkits , 2011, Human Genomics.
[17] Yoshihiro Yamanishi,et al. Predicting drug side-effect profiles: a chemical fragment-based approach , 2011, BMC Bioinformatics.
[18] Evan Bolton,et al. PubChem3D: a new resource for scientists , 2011, J. Cheminformatics.
[19] Carol Friedman,et al. Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis , 2011, J. Am. Medical Informatics Assoc..
[20] Evan Bolton,et al. PubChem3D: Biologically relevant 3-D similarity , 2011, J. Cheminformatics.
[21] Carol Friedman,et al. Enhancing Adverse Drug Event Detection in Electronic Health Records Using Molecular Structure Similarity: Application to Pancreatitis , 2012, PloS one.
[22] C. Bell,et al. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. , 2012, Drug safety.
[23] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[24] R. Altman,et al. Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.
[25] Carol Friedman,et al. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions , 2013, J. Am. Medical Informatics Assoc..
[26] P. Bork,et al. Systematic identification of proteins that elicit drug side effects , 2013, Molecular systems biology.
[27] N. Shah,et al. Performance of Pharmacovigilance Signal‐Detection Algorithms for the FDA Adverse Event Reporting System , 2013, Clinical pharmacology and therapeutics.
[28] D. Madigan,et al. Medication-Wide Association Studies , 2013, CPT: pharmacometrics & systems pharmacology.
[29] G Hripcsak,et al. Similarity-Based Modeling Applied to Signal Detection in Pharmacovigilance , 2014, CPT: pharmacometrics & systems pharmacology.
[30] Carol Friedman,et al. State of the art and development of a drug-drug interaction large scale predictor based on 3D pharmacophoric similarity. , 2014, Current drug metabolism.
[31] 正博 頭金. FDA adverse event reporting system (FAERS) , 2015 .